| CAR T cells in solid tumors: challenges and opportunities F Marofi, R Motavalli, VA Safonov, L Thangavelu, AV Yumashev, ... Stem cell research & therapy 12, 1-16, 2021 | 523 | 2021 |
| Mesenchymal stem/stromal cells as a valuable source for the treatment of immune-mediated disorders A Markov, L Thangavelu, S Aravindhan, AO Zekiy, M Jarahian, ... Stem cell research & therapy 12, 1-30, 2021 | 329 | 2021 |
| A paradigm shift in cell-free approach: the emerging role of MSCs-derived exosomes in regenerative medicine S Moghadasi, M Elveny, HS Rahman, W Suksatan, AT Jalil, ... Journal of translational medicine 19, 1-21, 2021 | 266 | 2021 |
| CAR‐NK cell in cancer immunotherapy; A promising frontier F Marofi, OF Abdul‐Rasheed, HS Rahman, HS Budi, AT Jalil, ... Cancer Science 112 (9), 3427-3436, 2021 | 212 | 2021 |
| Novel CAR T therapy is a ray of hope in the treatment of seriously ill AML patients F Marofi, HS Rahman, ZMJ Al-Obaidi, AT Jalil, WK Abdelbasset, ... Stem Cell Research & Therapy 12, 1-23, 2021 | 192 | 2021 |
| Mesenchymal stem/stromal cell-derived exosomes in regenerative medicine and cancer; overview of development, challenges, and opportunities A Hassanzadeh, HS Rahman, A Markov, JJ Endjun, AO Zekiy, ... Stem cell research & therapy 12 (1), 297, 2021 | 113 | 2021 |
| Mesenchymal stromal cells; a new horizon in regenerative medicine S Tavakoli, HR Ghaderi Jafarbeigloo, A Shariati, A Jahangiryan, F Jadidi, ... Journal of cellular physiology 235 (12), 9185-9210, 2020 | 74 | 2020 |
| Mesenchymal stromal cells (MSCs) for neurodegenerative disease: a promising frontier A Shariati, R Nemati, Y Sadeghipour, Y Yaghoubi, R Baghbani, K Javidi, ... European journal of cell biology 99 (6), 151097, 2020 | 74 | 2020 |
| CAR-engineered NK cells; a promising therapeutic option for treatment of hematological malignancies F Marofi, MM Saleh, HS Rahman, W Suksatan, ME Al-Gazally, ... Stem cell research & therapy 12 (1), 374, 2021 | 58 | 2021 |
| The role of XIAP in resistance to TNF-related apoptosis-inducing ligand (TRAIL) in Leukemia R Saraei, M Soleimani, AAM Akbari, MF Hagh, A Hassanzadeh, S Solali Biomedicine & Pharmacotherapy 107, 1010-1019, 2018 | 46 | 2018 |
| Down‐regulation of intracellular anti‐apoptotic proteins, particularly c‐FLIP by therapeutic agents; the novel view to overcome resistance to TRAIL A Hassanzadeh, M Farshdousti Hagh, MR Alivand, AAM Akbari, ... Journal of cellular physiology 233 (10), 6470-6485, 2018 | 45 | 2018 |
| Nanoparticles in cancer immunotherapies: An innovative strategy P Nasirmoghadas, A Mousakhani, F Behzad, N Beheshtkhoo, ... Biotechnology progress 37 (2), e3070, 2021 | 40 | 2021 |
| Leukemia therapy by flavonoids: Future and involved mechanisms R Saraei, F Marofi, A Naimi, M Talebi, M Ghaebi, N Javan, O Salimi, ... Journal of cellular physiology 234 (6), 8203-8220, 2019 | 39 | 2019 |
| Flavonoid-based cancer therapy: an updated review E Hosseinzadeh, A Hassanzadeh, F Marofi, MR Alivand, S Solali Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2020 | 37 | 2020 |
| Quercetin sensitizes human myeloid leukemia KG‐1 cells against TRAIL‐induced apoptosis A Naimi, A Entezari, MF Hagh, A Hassanzadeh, R Saraei, S Solali Journal of cellular physiology 234 (8), 13233-13241, 2019 | 35 | 2019 |
| Mesenchymal stem cells as the game‐changing tools in the treatment of various organs disorders: mirage or reality? F Marofi, G Vahedi, A Hasanzadeh, S Salarinasab, P Arzhanga, ... Journal of Cellular Physiology 234 (2), 1268-1288, 2019 | 33 | 2019 |
| Epigenetic mechanisms are behind the regulation of the key genes associated with the osteoblastic differentiation of the mesenchymal stem cells: The role of zoledronic acid on … F Marofi, A Hassanzadeh, S Solali, G Vahedi, R Mousavi Ardehaie, ... Journal of cellular physiology 234 (9), 15108-15122, 2019 | 31 | 2019 |
| Genetically-modified stem cell in regenerative medicine and cancer therapy; a new era A Hassanzadeh, S Shamlou, N Yousefi, M Nikoo, J Verdi Current gene therapy 22 (1), 23-39, 2022 | 28 | 2022 |
| Stem cell in neurodegenerative disorders; an emerging strategy M Ahani‐Nahayati, A Shariati, M Mahmoodi, A Olegovna Zekiy, K Javidi, ... International Journal of Developmental Neuroscience 81 (4), 291-311, 2021 | 25 | 2021 |
| Quercetin promotes cell cycle arrest and apoptosis and attenuates the proliferation of human chronic myeloid leukemia cell line-K562 through interaction with HSPs (70 and 90 … A Hassanzadeh, E Hosseinzadeh, S Rezapour, G Vahedi, N Haghnavaz, ... Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2019 | 25 | 2019 |
